$1.17
0.0554.95%
Last update: Nov 11, 1:21 PM
ProKidney Corp
PROKNASDAQ
ProKidney fell 60.4% from $2.80 to $1.11, behind the S&P 500's +9.8%. Its worst day was Nov 13 (−14.9%), and its low came Nov 5 at $1.07.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
ProKidney shares fell 14.9%, while the S&P 500 fell 1.7%.
−14.9%, the year's worst day · S&P 500 −1.7%
ProKidney shares fell 13.0%, while the S&P 500 fell 0.4%.
−13.0% · S&P 500 −0.4%
Story events cover the past 12 months · Times ET
EPS of $-0.14 beat the $-0.15 estimate on $225,000.00 revenue (est. $100,360.00).
−6.3% · S&P 500 −0.5%
EPS of $-0.14 beat the $-0.14 estimate on $226,000.00 revenue (est. $94,200.00).
−2.9% · S&P 500 −1.2%
EPS of $-0.15 missed the $-0.14 estimate on $150,000.00 revenue (est. $163,200.00).
−4.7% · S&P 500 −0.3%
ProKidney shares rose 13.4%, while the S&P 500 rose 0.4%.
+13.4%, the year's best day · S&P 500 +0.4%
ProKidney closed at its lowest level of the year, 62.0% below where the year started.
−4.9% · S&P 500 −4.4%
Where it ended: a close of $1.11 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.14, revenue est. $139,680.00).
Nothing in the past 12 months.
All PROK dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PROK and SPY from Benzinga historical bars. Not investment advice.
